AAAAAA
Results:
1-7
|
Results: 7
Authors:
Garbern, J
Shy, M
Krajewski, K
Kamholz, J
Hobson, G
Cambi, F
Citation: J. Garbern et al., Evidence for neuroaxonal injury in patients with proteolipid gene mutations, NEUROLOGY, 57(10), 2001, pp. 1938-1939
Authors:
Ruan, BF
Wilson, WK
Pang, JH
Gerst, N
Pinkerton, FD
Tsai, J
Kelley, RI
Whitby, FG
Milewicz, DM
Garbern, J
Schroepfer, GJ
Citation: Bf. Ruan et al., Sterols in blood of normal and Smith-Lemli-Opitz subjects, J LIPID RES, 42(5), 2001, pp. 799-812
Authors:
Awatramani, R
Beesley, J
Yang, HB
Jiang, HY
Cambi, F
Grinspan, J
Garbern, J
Kamholz, J
Citation: R. Awatramani et al., Gtx, an oligodendrocyte-specific homeodomain protein, has repressor activity, J NEUROSC R, 61(4), 2000, pp. 376-387
Authors:
Jiang, HY
Duchala, CS
Awatramani, R
Shumas, S
Carlock, L
Kamholz, J
Garbern, J
Scherer, SS
Shy, ME
Macklin, WB
Citation: Hy. Jiang et al., Proteolipid protein mRNA stability is regulated by axonal contact in the rodent peripheral nervous system, J NEUROBIOL, 44(1), 2000, pp. 7-19
Authors:
Krajewski, KM
Lewis, RA
Fuerst, DR
Turansky, C
Hinderer, SR
Garbern, J
Kamholz, J
Shy, ME
Citation: Km. Krajewski et al., Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A, BRAIN, 123, 2000, pp. 1516-1527
Authors:
Kamholz, J
Menichella, D
Jani, A
Garbern, J
Lewis, RA
Krajewski, KM
Lilien, J
Scherer, SS
Shy, ME
Citation: J. Kamholz et al., Charcot-Marie-Tooth disease type 1 - Molecular pathogenesis to gene therapy, BRAIN, 123, 2000, pp. 222-233
Authors:
Garbern, J
Cambi, F
Shy, M
Kamholz, J
Citation: J. Garbern et al., The molecular pathogenesis of Pelizaeus-Merzbacher disease, ARCH NEUROL, 56(10), 1999, pp. 1210-1214
Risultati:
1-7
|